Q4 2024 Earnings Conference Call February 7, 2025 3:00 AM ETCompany ParticipantsNicolas Hieronimus - CEOChristophe Babule ...

Earnings Call Transcript January 30, 2025 Sanofi misses on earnings expectations. Reported EPS is $0.7 EPS, expectations were $0.71. Thomas Larsen: Welcome to the Q4 and Full Year 2024 Conference Call ...

DNA (deoxyribonucleic acid), the molecular "blueprint" carrying the genetic instructions that influence the growth, ...

Two new studies represent a big step toward developing innovative molecular therapies capable of disrupting the ...

RBC Capital analyst Lisa Walter reiterated a Buy rating on 4D Molecular Therapeutics (FDMT – Research Report) today and set a price target of $39.00. The company’s shares opened today at $6.09.

Quantum spin liquids are fascinating states of matter where magnetic spins stay disordered, defying the usual rules of magnetism. Scientists have made an exciting discovery about one such material.

4D Molecular (FDMT) presented 52-week wet age-related macular degeneration Phase IIb results at this weekend’s Angiogenesis, Exudation, and Degeneration meeting, and while there was some ...

The international team describes their results and the underlying molecular mechanism in Cell Metabolism. Ergothioneine is a natural compound found in certain fungi such as oyster or shiitake ...

In addition to the efforts toward building upon the FP features, we also aim to develop novel molecular dynamics (MD)-derived amino acid features. We create features for amino acids based on the MD ...